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Abstract 
Background: Translocated in LipoSarcoma (TLS, also known as FUsed in Sarcoma) is an RNA/DNA binding protein 
whose mutation cause amyotrophic lateral sclerosis. In previous study, we demonstrated that TLS binds to long 
noncoding RNA, promoter-associated ncRNA-D (pncRNA-D), transcribed from the 5′ upstream region of cyclin D1 
(CCND1), and inhibits the expression of CCND1.
Results: In order to elucidate the binding specificity between TLS and pncRNA-D, we divided pncRNA-D into seven 
fragments and examined the binding with full-length TLS, TLS–RGG2–zinc finger–RGG3, and TLS–RGG3 by RNA 
pull down assay. As a result, TLS was able to bind to all the seven fragments, but the fragments containing reported 
recognition motifs (GGUG and GGU) tend to bind more solidly. The full-length TLS and TLS–RGG2–zinc finger–RGG3 
showed a similar interaction with pncRNA-D, but the binding specificity of TLS–RGG3 was lower compared to the full-
length TLS and TLS–RGG2–zinc finger–RGG3. Mutation in GGUG and GGU motifs dramatically decreased the binding, 
and unexpectedly, we could only detect weak interaction with the RNA sequence with stem loop structure.
Conclusion: The binding of TLS and pncRNA-D was affected by the presence of GGUG and GGU sequences, and the 
C terminal domains of TLS function in the interaction with pncRNA-D.
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Background
Translocated in LipoSarcoma [TLS, also known as FUsed 
in Sarcoma (FUS)] is an RNA/DNA binding protein 
whose mutation causes amyotrophic lateral sclerosis 
(ALS). Mutations in TLS, especially those at the C ter-
minus of TLS, disrupt TLS transportation to the nucleus, 
and result in ALS [1–3]. In previous study, we demon-
strated that long noncoding RNAs (lncRNAs) transcribed 
from the 5′ upstream region of cyclin D1 (CCND1), and 
these lncRNA are expected to bind to TLS and inhibits 
the histone acetyltransferase activity of CBP/p300 at the 
CCND1 promoter. This interaction subsequently inhibits 
the expression of CCND1 [4]. During this mechanism, 
binding between the lncRNA, promoter-associated non-
coding RNA (pncRNA), and TLS changes the structure 
of TLS and allows it to interact with CBP/p300. There-
fore, understanding the binding mechanism between 
TLS and pncRNA is an important issue in regulation of 
gene expression programs in eukaryotic cells.
Recent studies revealed that lncRNAs are mainly 
involved in gene silencing, but their mechanisms are not 
fully understood, especially for the binding between the 
lncRNA and the RNA binding proteins. Various lncRNAs 
have been reported to bind to RNA binding proteins [5]. 
One of the well-described lncRNA, Xist, binds to RNA 
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binding protein SHARP to inhibit the expression of tar-
get genes [6]. Several reports revealed that TLS could 
also interact with thousands of RNAs including lncRNAs 
[7, 8].
TLS consists of SYGQ-rich domain, RNA recognition 
motif (RRM), zinc finger domain, and three RGG repeat 
domains. TLS binds to numerous number of RNAs, 
which are involved in cell cycle, RNA splicing, cellular 
response to stress and DNA repair, and so on [9]. RRM 
domain is usually expected to function in the binding 
between RNA, but whether RRM domain of TLS func-
tions in the binding with RNAs is controversial [10–13]. 
According to our binding assay, pncRNA showed a strong 
binding to the C terminal domains of TLS but not to the 
N-terminal and RRM domains. Therefore, we examined 
the precise binding between lncRNA and the C terminal 
domains (RGG2–zinc finger–RGG3 domains and RGG3 
domain) of TLS in this study.
There are several TLS recognition motifs reported 
by different groups, such as GGUG, GGU, GUGG, and 
CGCGC-motifs in RNAs [14–16], but its binding tends 
to be remarkably flexible. Wang et al. reported that TLS 
bind to RNA in the length dependent manner, and the 
mutation in the known binding motifs did not show a 
dramatic decrease in the binding [13], supporting the low 
specificity of the RNA binding of TLS.
In this study, we focused on one of the lncRNAs tran-
scribed from the promoter region of CCND1, pncRNA-
D, since it showed the highest expression level among the 
pncRNAs. We determined the full-length of pncRNA-D, 
and examined in which sequence TLS binds to by divid-
ing pncRNA-D into seven fragments. We demonstrated 
that TLS strongly binds to 5′ and the 3′ ends of pncRNA-
D, but could bind to fragments which do not contain any 
of the known binding motifs. Furthermore, we showed 
that the RGG2–zinc finger–RGG3 domains at the C ter-
minal of TLS function in the interaction with pncRNA-D. 
In addition, the mutation in GGUG or GGU sequences 
dramatically decreased the binding between pncRNA-D 
and TLS.
Results
TLS bound strongly to the 5′ and the 3′ end of pncRNA‑D
Among the lncRNAs expressed from the promoter 
region of CCND1, pncRNA-D showed the highest 
expression level in the previous study [4]. Therefore, we 
performed 5′ and 3′ RACE to determine the full-length 
of pncRNA-D. As a result, we found that pncRNA-D 
was a polyadenylated lncRNA with the length of 602 nt 
with single exon (Fig. 1a and Additional file 1: Figure S1). 
Then we examined if there were any open reading frames 
(ORFs) by ORF finder (http://www.ncbi.nlm.nih.gov/
gorf/gorf.html). We detected three ORFs with length of 
10–50 amino acids, but could not find any known protein 
domains in any of the expected short peptides (data not 
shown).
Since TLS is expected to bind to RNA with GGUG, 
GGU, GUGG, and CGCGC-motifs [14–16], we searched 
for these motifs in the 602 nt pncRNA-D, and found 
five GGUGs and five GGUs (excluding GGU in GGUG 
motif ) at the positions indicated in Fig. 1a, but there was 
no CGCGC sequence. Next, we examined the binding 
between TLS and fragmented pncRNA-Ds. We divided 
pncRNA-D into seven fragments, and generated bioti-
nylated RNA oligonucleotides. The result of binding 
assay indicated that full-length TLS protein were likely 
to interact with all the fragments investigated (Fig. 1b), 
though it showed a slight difference in the intensity of 
the binding. TLS bound strongly to the 5′ and 3′ end 
fragments of pncRNA-D, where GGUG and GGU 
sequences exist, but we have to note that TLS also bound 
to fragments 3 and 4 which do not have GGUG or GGU 
sequences, although the binding was weaker compared 
to other fragments.
We next examined more precise binding between TLS 
and fragments 1 and 7, since they showed stable interac-
tion with TLS. Fragments 1 and 7 were shortened to 31 nt 
(fragment 1–1) and 53 nt (fragment 7–1) around GGUG 
sequences, respectively, and the result of binding assay 
demonstrated fragments 1–1 and 7–1 could still bind 
to TLS (Fig. 1c). The binding between TLS and random 
RNA oligonucleotide was also examined, but we only 
detected marginal interaction compared to pncRNA-D 
fragment 1–1 (Additional file 1: Figure S2).
The secondary structure of the fragment 1–1 determined 
by NMR
We were interested in the fragment 1–1 (pncRNA-D 
nucleotides 32–62), since it showed the strong bind-
ing with TLS, and the in silico analysis implicated that 
the fragment 1–1 form stem loop structure (Fig.  2a) 
To determine the secondary structure of the fragment 
1–1, NMR analysis was performed. Figure 2b shows the 
imino–imino and imino–amino/base proton regions 
of a NOESY spectrum of the fragment 1–1. The obser-
vation of a strong cross peak between two resonances 
at 10.6  ppm and 11.8  ppm (Fig.  2b, left) indicates the 
presence of a G:U base pair. The proton resonance at 
13.3 ppm gave strong cross peaks to two amino protons 
(Fig.  2b, right), which indicates that the 13.3  ppm reso-
nance is an imino proton one of G involved in a G:C base 
pair. The proton resonance at 13.9  ppm gave a strong 
cross peak to AH2 (Fig.  2b, right), which indicates that 
the 13.9  ppm resonance is an imino proton one of U 
involved in an A:U base pair. A cross peak between 11.8 
and 13.3  ppm resonances and one between 13.3 and 
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13.9 ppm resonances indicates the presence of consecu-
tive G:U, G:C and A:U base pairs for the fragment 1–1 
[17, 18].
Then, the fragment 1–1 was divided into two frag-
ments, the 5′ end (pncRNA-D nucleotides 32–44) and 
the 3′ end of the fragment 1–1 (pncRNA-D nucleotides 
44–62, Fig. 2e top table). The imino proton spectrum of 
the 3′ end of the fragment 1–1 turned out to be almost 
identical to that of the fragment 1–1 (Fig.  2c), which 
indicates that the consecutive three base pairs found for 
the fragment 1–1 are formed in a 3′-region of the frag-
ment 1–1 and that basically no base pair is formed in a 
5′-region of the fragment 1–1. Figure 2d shows two possi-
ble secondary structures of the fragment 1–1 that involve 
the consecutive three base pairs. The imino proton spec-
trum of the G49A mutant of the 3′ end of the fragment 
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Fig. 1 The binding between full-length TLS and fragmented pncRNA-Ds. a The position of pncRNA-D and CCND1. The fragmented pncRNA-Ds are 
shown at the bottom. Black and white boxes indicate GGUG and GGU sequence, respectively. Since fragment 3 and 4 did not contain any GGUG 
or GGU motifs, we considered them as a negative control. b and c Western blot analysis were conducted with HeLa nuclear extract (NE). Seven 
fragmented pncRNA-Ds (b) and shortened fragment 1 and 7 (c) were incubated with HeLa NE, and the affinity between TLS and each fragment was 
examined by RNA pull down assay. Five and ten percent of the protein used for RNA pull down assays were loaded as input N = 5




Fig. 2 The binding between full-length TLS and the fragment 1–1. a Computational analysis predicting the secondary structure of pncRNA-D by 
CentroidFold (http://www.ncrna.org/centroidfold/). The position of the fragment 1–1 is shown in red box. b Imino-imino (left) and imino-amino/
base (right) proton regions of a NOESY spectrum with a mixing time of 300 ms, the assignments of imino protons being indicated. Cross peaks to 
two amino protons and H2 are boxed, respectively. c 1D imino proton spectra of the fragment 1–1, the 3′ end of the fragment 1–1, G49A mutant of 
the 3′ end of the fragment 1–1 and G46A mutant of the 3′ end of the fragment 1–1, respectively, from top to bottom. d The two possible second-
ary structures of the fragment 1–1, the upper one being concluded as a right one. e Western blot analysis were performed to detect the binding 
between 5′ and 3′ ends of the fragment 1–1. Ten percent of the protein used for RNA pull down assay was loaded as input N = 5
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1–1 is similar to that of the 3′ end of the fragment 1–1, 
while almost no imino proton resonance is observed 
for the G46A mutant (Fig. 2c). This revealed that G49 is 
not critical for the formation of the secondary structure, 
while G46 is indispensable for the formation of the sec-
ondary structure. Thus, it is concluded that the fragment 
1–1 formed the secondary structure shown in the upper 
of Fig. 2d.
We were interested in which end of the fragment 1–1 
interacts with TLS, and performed the binding assay. 
Unexpectedly, TLS bound to the 5′ end of the fragment 
1–1 and not to the 3′ end, which formed the stem loop 
structure (Fig. 2e, bottom). Taken together, TLS is likely 
to recognize the sequence of RNA rather than the sec-
ondary structure when binding the fragment 1–1.
The C terminal zinc finger domain enhanced the specificity 
of the binding between TLS and pncRNA‑D
Next we investigated the binding of truncated TLS frag-
ments. We generated the GST-tagged TLS-1 to -5 as in 
Fig.  3a, and performed RNA pull down assay with full 
length pncRNA-D (602 nt), and pncRNA-D fragment 1 
and 7, which showed an effective binding with full-length 
TLS (Fig. 1b). As a result, TLS-4 (TLS amino acids 373–
526, containing RGG2, zinc finger, and RGG3 domains) 
and -5 (TLS amino acids 449–526, containing RGG3 
domain) were able to bind to the RNAs examined. On the 
other hand, we observed merely slight binding of TLS-1 
to the RNA oligonucleotides, and did not detect any sig-
nificant binding of TLS- 2 or -3 (Fig. 3b).
We then investigated the binding of TLS-4 and -5 with 
RNAs examined in Fig. 1b. TLS-4 bound firmly to the 5′ 
end (fragment 1) and the 3′ end (fragment 7) of pncRNA-
D, but slightly bound to fragments 3, 4 or 5 (Fig. 3c, top). 
TLS-5 was able to bind to all the RNA fragments, but 
its specificity decreased compared to full-length TLS 
and TLS-4 (Fig.  3c, bottom). We further examined the 
binding of TLS-4 and -5 to short pncRNA-D sequences 
(Fig.  3d). Both TLS-4 and -5 could bind specifically to 
the fragment 1–1, 7–1, and the 5′ end of the fragment 
1–1, but bound slightly to the 3′ end of the fragment 1–1. 
These data suggest that TLS binds to pncRNA-D mainly 
through RGG domains, and zinc finger domain increased 
the specificity of the binding.
The titration experiments with NMR revealed that TLS‑5 
interacts with a 5′‑region of the fragment 1–1 more 
intensively than a 3′‑region
Since the TLS showed a higher affinity to the 5′ end of 
the fragment 1–1 compared to the 3′ end of the frag-
ment 1–1, which formed the stem loop structure, we 
further examined their binding with NMR analysis. In 
a course of the gradual addition of the fragment 1–1 to 
15N-labeled TLS-5, 1H–15N HSQC correlation peaks 
of TLS-5 almost disappeared due to line broadening 
of each correlation peak at the 1:0.5 molar ratio, then, 
the correlation peaks re-appeared when the fragment 
1–1 was further added (Fig.  4a). This kind of spectral 
change is typically observed when protein (TLS-5 in 
this case) in free and protein in complex with RNA (the 
fragment 1–1 in this case) undergoes the intermediate 
exchange regime in an NMR chemical shift time scale. 
Thus, the interaction of TLS-5 with the fragment 1–1 is 
clearly detected by NMR. The similar spectral change 
was observed when the 5′ end of the fragment 1–1 was 
gradually added (Fig. 4b). In this case, however, the dis-
appearance occurred at the 1:1 molar ratio. The line 
broadening due to the intermediate exchange regime 
is known to be most remarkable when a half amount 
of protein is in a free form and another half amount of 
protein is in a complex form. In the case of the fragment 
1–1, this situation was satisfied when the molar ratio 
was 1:0.5, while in the case of the 5′ end of the fragment 
1–1, further addition of the 5′ end of the fragment 1–1 
(the molar ratio of 1:1) was needed to reach this situa-
tion. This indicates that the 5′ end of the fragment 1–1 
binds to TLS-5 less strongly than the fragment 1–1.
In a course of the gradual addition of the 3′ end of the 
fragment 1–1, in contrast, disappearance of correlation 
peaks did not occur, but gradual change of the positions 
of correlation peaks was observed (Fig.  4c). This kind 
of spectral change is typically observed when protein 
(TLS-5 in this case) in free and protein in complex with 
RNA (the 3′ end of the fragment 1–1 in this case) under-
goes the fast exchange regime in an NMR chemical shift 
time scale. Usually, the affinity of the complex is lower 
for the fast exchange regime than for the intermediate 
exchange regime. Thus, it is suggested that the 3′ end of 
the fragment 1–1 binds to TLS-5 less strongly than the 5′ 
end of the fragment 1–1. The spectral change in a course 
of the gradual addition of U13 was similar to that of the 
3′ end of the fragment 1–1 (Fig. 4d).
The dissociation constant of the TLS-5: the 3′ end of 
the fragment 1–1 complex was determined on the basis 
of the curve fitting on the gradual change of the positions 
of correlation peaks in a course of the gradual addition of 
the 3′ end of the fragment 1–1 (Additional file 1: Figure 
S3). The dissociation constant of 3.5 ± 1.9 × 10−6 M was 
obtained. The dissociation constant of the TLS-5: U13 
complex was estimated in the same way to be roughly 
2 × 10−5 M, although a precise value was difficult to be 
deduced due to weaker affinity. In a case of intermedi-
ate exchange regime, the dissociation constant cannot 
be obtained by curve fitting. As mentioned above, how-
ever, the affinity of the complex is usually lower for the 
fast exchange regime than for the intermediate exchange 
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regime, probably at least by ca. 10 times. Thus, the dis-
sociation constant of the TLS-5: the 5′ end of the frag-
ment 1–1 complex was supposed to be approximately 
3.5  ×  10−7 M or even smaller. Finally, the dissociation 
constant of the TLS-5: the fragment 1–1 complex was 
supposed to be smaller than around 3.5  ×  10−7 M. In 
summary, TLS-5 interacts with the 5′-region of the frag-
ment 1–1 more firmly than a 3′-region.
SYGQ-Rich RGG1 RRM ZF RGG3RGG2 TLS/FUS
TLS-4ZF RGG3RGG2GST










































Fig. 3 The binding between truncated TLS and pncRNA-D. a The domain structure of TLS. GST tag was attached to the 5′ end of the truncated 
TLS-1 to -5. RGG RGG repeat domain, RRM RNA recognition motif, ZF zinc finger domain. b The interaction between TLS-1 and -5 and pncRNA-D 
with different length was examined by RNA pull down assay. N = 3. c Binding of TLS-4 (top) and -5 (bottom) with fragmented pncRNA-D were exam-
ined by RNA pull down assay followed by western blot analysis. Purified TLS-4 and TLS-5 were incubated with pncRNA-D fragments, and the signals 
were detected with anti-GST antibody. N = 5. d The binding between the fragments 1–1, 7–1, the 5′ end and the 3′ end of fragment 1–1 with TLS-4 
or TLS-5 were examined by RNA pull down assay as in (b) and (c). N = 4. In all the experiments, 10 % of the protein used for RNA pull down assay 
was loaded as input
Page 7 of 12Yoneda et al. Cell Biosci  (2016) 6:4 
Fig. 4 NMR titration experiments for TLS-5 with the fragment 1–1, the 5′ end of the fragment 1–1, the 3′ end of the fragment 1–1 and U13. a and 
b 1H–15N HSQC spectra of TLS-5 with either the fragment 1–1 (a), the 5′ end of the fragment 1–1 (b), the 3′ end of the fragment 1–1 (c) or U13 (d), 
with the molar ratios of 1:0, 1:0.5, 1:1.0, 1:1.5 and 1:2.0, respectively
Page 8 of 12Yoneda et al. Cell Biosci  (2016) 6:4 
The mutation of GGUG and GGU sequences dramatically 
decreased the binding
Finally, we examined the effect of the mutation of GGUG 
and GGU into CCUC and CCU, respectively, in the short 
RNA sequences on the TLS binding. The fragment 1–1 
had GGU and GGUG sequence at the positions indicated 
in Fig.  5a, left. Therefore, we generated two mutated 
fragments in the fragment 1–1 (m1 and m2), and one 
for the 5′ end of the fragment 1–1 (m3) as listed in the 
table (Fig. 5a, right). As a result, each mutation dramati-
cally reduced the binding of full-length TLS, TLS-4, and 
TLS-5 (Fig. 5b). Interestingly, the mutated fragments had 
a different effect in the binding. The m2 mutation (GGU 
to CCU at the 5′ end) decreased the interaction more 
effectively than the m1 mutation (GGUG to CCUC at the 
3′ end) of the fragment 1–1. This data supports the fact 
that TLS preferentially binds to the 5′ end of the frag-
ment 1–1 (Figs. 2e and 3d).
Discussion/Conclusion
Significant percentages of the human genome have been 
shown to be transcribed into RNAs, while most of them 
are supposed to be lncRNAs. Therefore, it is increasing 
impact on assigning functions to these lncRNA. How-
ever, relatively small numbers of reports have been show-
ing biological functions of lncRNAs because of lacking 
full-length sequence and structural data of lncRNAs. In 
this study, we have determined the exact RNA sequence 
of pncRNA-D and deduced specific secondary struc-
tures with NMR analysis. These data present support-
ive information which boosts whole area of the lncRNA 
investigations.
There are several experimental techniques employed 
to detect the protein–RNA interactions, such as electro-
phoretic mobility shift assay (EMSA), FISH assay, and 
RNA pull-down assay [13, 19, 20]. In the previous study, 
we employed EMSA [4], because it is commonly used 
technology to detect RNA binding to proteins. However, 
we encountered some difficulties, for instances, insta-
bility of detection of signals, and handling of relatively 
higher exposure to radioactivity of 32P-probes. There-
fore, we have developed the RNA pull down assay using 
biotinylated RNA oligonucleotides with TLS. The assay 
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Fig. 5 The effect of the mutation (GGUG to CCUC; GGU to CCU) on the binding of the fragment 1–1 and TLS. a The position of GGU and GGUG 
where mutation was induced in the fragment 1–1 is shown in black box (left), and the RNA sequences are listed in the table (right). Sequence of the 
5′ end of the fragment 1–1 is underlined. b The binding between mutated fragments and full-length TLS, TLS-4, and TLS-5 was examined by RNA 
pull down assay N = 3. Ten percent of the protein used for RNA pull down assay was loaded as input
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Another option for detection of RNA in cells is FISH 
assay. FISH assay is not applicable to our experiments 
since the expression level of pncRNA-D was under the 
detection level with it.
TLS preferentially bound the 5′ and 3′ regions (frag-
ments 1, 2 and 6, 7) of the seven fragments over the full-
length pncRNA-Ds, although certain levels of binding 
were detected in the middle fragments (fragments 3, 4, 
and 5) (Figs. 1b and 3b). The both edges of the pncRNA-
D have the GGUG and GGU motifs and the middle 
fragments does not possess them, suggesting that these 
motifs could confer the binding preference for TLS. Actu-
ally, the mutational experiments using the RNA oligonu-
cleotides of pncRNA-D (nucleotides 32–62: the fragment 
1–1) with the GGUG and GGU motifs confirm that they 
have crucial roles in the binding to TLS in biochemi-
cal environments (Fig.  5b). In silico analysis predicted 
that the 3′ end of the fragment 1–1 forms the stem loop 
structure. The NMR analysis confirmed that the 3′ end of 
the fragment 1–1 forms the stem loop structure (Fig. 2) 
and the 5′ end does not form any stable structure indi-
cating the 5′ end as natively unfolded status. It has been 
reported that TLS preferentially bind to the stem loop 
structure [7, 14]. Contrast to previous reports, our exper-
iments demonstrated that TLS bound to the 5′ end of the 
fragment 1–1, bearing natively unfolded status instead of 
the 3′ end, which forms the stem loop structure.
Comparing the binding of RGG3 domain of TLS (TLS-
5) to the fragment 1–1 and just the 5′ end of the frag-
ment 1–1 with the NMR analysis, the whole fragment 
1–1 (pncRNA-D nucleotide 32–62) turned out to have 
more solid binding than the 5′ end of the fragment 1–1 
(pncRNA-D nucleotide 32–44) (Fig.  4). On the other 
hand, the RNA pull down assay (Fig.  3d) showed that 
TLS-5 bound more firmly to the 5′ end of the fragment 
1–1 than the 3′ end. In addition, presence of the 3′ end of 
the fragment 1–1 (pncRNA-D nucleotide 44–62) reduced 
the interaction between TLS-5 and the fragment 1–1 
(Fig.  5b, comparing the binding between m2 and m3). 
This discrepancy of these two results might be caused 
from the difference in experimental conditions between 
the NMR analysis and the RNA pull down assay. How-
ever, our preliminary RNA pull down experiments incu-
bating the nuclear extract of HeLa cells with both 5′ and 
the 3′ ends of the fragment 1–1 indicated that both edges 
captured certain numbers of proteins (data not shown). 
These data indicate that the 3′ end of the fragment 1–1 
might play a regulatory role on the interaction between 
the RNA and TLS.
The interaction of full-length TLS and TLS-4 with 
seven fragments of pncRNA-D showed a similar pro-
file (Figs. 1b and 3b). On the other hand, the binding of 
TLS-5 to these RNA fragments was more labile and the 
specificity tends to be lower compared to the full-length 
TLS and TLS-4. These data demonstrate that the RGG2–
zinc finger–RGG3 domain (TLS-4) is mainly involved in 
the binding with pncRNA-D, and the zinc finger domain 
enhances the specificity and the intensity of the binding. 
Indeed, the zinc finger domain could enhance the pro-
tein–RNA interaction [21, 22].
TLS has been found to accommodate more than 30,000 
RNA species (data not shown). Our binding experiments 
in this study indicated that some RNA molecules have 
high specificity and others have low specificity, inspiring 
that TLS binds to RNA in a different molecular mecha-
nism. In this study we identified some RNA sequences 
bound to TLS with high specificity (for example, at the 
fragments 1 and 7), other RNA sequences bound to TLS 
with low specificity (at the fragments 3 and 4), inspir-
ing that TLS binds to these two categories of RNA frag-
ments through distinctive surface(s) of the molecule. 
For another example, the Thomas Cech group reported 
that TLS binds to RNAs without any identified recog-
nition motifs (such as GGUG), and mutations in those 
motifs slightly decrease the related bindings [13]. These 
are a category of the RNA binding with low specificity. 
Contrarily, our experiments in this study have shown a 
distinctive category of the RNA binding, the highly spe-
cific binding of TLS to pncRNA-D through characteristic 
motifs like GGUG and GGU (Fig. 5). Taken together, we 
present that distinct specificities of the RNA binding of 
TLS functions in cells, suggesting that they should play 
each specific role in supporting biological events each in 
development and homeostasis programs of eukaryotes.
Methods
Cell culture and nuclear extract preparation
Hela cells were cultured as previously described [23]. For 
nuclear extract preparation, HeLa cells were cultured 
in 15  cm dishes. HeLa cells were washed with PBS and 
collected in 5  ml phosphate buffered saline (PBS), and 
centrifuged at 800×g for 5  min. Supernatant was dis-
carded and the cells were resuspended in 2.5 ml of Hypo-
tonic buffer (10  mM HEPES, 1.5  mM MgCl2, 10  mM 
KCL, 0.5  mM DTT, 0.2  mM PMSF), and centrifuged at 
1100×g  rpm for 1  min. After removing all the super-
natant, the cells were resuspended in 10  ml Hypotonic 
buffer, and kept on ice for 10 min. The cells were homog-
enized with digital homogenizer (1500 rpm, 10 min with 
gentle up and down), and the samples were centrifuged 
at 1100×g for 20 min (precipitation is nuclei). The nuclei 
were resuspended in High salt buffer (20  mM HEPES, 
1.5 mM MgCl2, 0.6 M NaCl, 0.2 mM EDTA, 25 % Glyc-
erol, 0.5  mM DTT, 0.2  mM PMSF), and rotated for 
30 min in 4 °C. The sample was centrifuged at 20,000×g 
for 30  min, and the supernatant was collected and 
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dialyzed in dialysis buffer (20 mM HEPES, 0.1 M NaCl, 
0.2  mM EDTA, 20  % Glycerol, 0.5  mM DTT, 0.2  mM 
PMSF) for 18 h.
5′ and 3′ RACE
5′ and 3′ RACE were performed using 5′-Full RACE 
Core Set (TaKaRa) and 3′-Full RACE Core Set 
(TaKaRa) according to the manufacturer’s protocols. 
The primers used in 5′ RACE were 5′ end-phospho-
rylated RT Primer: P-GGACTGAATTCGTG, 1st PCR 
primers: S1:GTTTAATTGATAATTGTTCTG and A1:CG 
AGTGTACTGATCTGAT, 2nd PCR primers: S2:AT 
TATGCCGGCTCCTGCCAG and A2:CGATAGGTGTT 
CGTGGTTAC. Primers used in 3′ RACE were Reverse 
transcription primer; oligo(dT)-containing Adapter 
Primer: GGCCACGCGTCGACTAGTACTTTTTTTTT 
TTTTTTTT, 1st PCR primers: Gene-Specific Primer 1 
(GSP 1): TTTTTCTATCAGTTTTCTTTGAGCTTTT 
AC, Abridged Universal Amplification Primer 1(AUAP 
1): GGCCACGCGTCGACTAGTAC, 2nd PCR primers: 
GSP2: GAGGGTACGGTGGTTTGATGACACTGAAC, 
AUAP2: GGCCACGCGTCGACTAG, and 3rd PCR prim-
ers: AUAP2 and GSP3: GCACCAAAGAGACAGAACC 
TGTAATTTTAAAAACTGTG.
Overexpression of GST–TLS‑4
GST–TLS-4 were overexpressed and purified as pre-
viously described [24]. Briefly, the ORF of TLS-4 was 
inserted into pGEX-KG vector, and transfected into 
Y1090. The expression of GST–TLS-4 were induced by 
IPTG, and the protein were purified with Glutathione 
beads. The purified GST–TLS-4 proteins were used for 
RNA binding assay.
RNA pull down assay
Biotinylated RNAs (fragmented pncRNA-Ds, mutated 
the fragment 1–1 and the 5′ end of fragment 1–1) were 
purchased from Integrated DNA Technologies MBL. 
Dynabeads-M280 was washed with PBS/0.02 % tween 20, 
and resuspended with whole cell extract (WCE) buffer 
containing tRNA (1 μg/μl) and RNase Inhibitor (4 U/μl). 
20 pmol RNA oligonucleotides were added to the beads, 
and incubated for 15 min at room temperature with rota-
tion. After 15 min of rotation, 100 μl of HeLa cell nuclear 
extract (to detect full-length TLS) or 3 μg of GST–TLS-4 
or -5 were added and incubated for 1 h at 4 °C with rota-
tion. The beads were washed with 1 ml WCE buffer for 
four times, and resuspended in 2× sodium dodecyl sul-
fate (SDS) sample buffer (0.25  M Tris–HCl pH 6.8, 4  % 
SDS, 10 % 2-mercaptoethanol, 20 % glycerol). The sam-
ples were boiled at 100 °C for 3 min, and the dynabeads 
were removed by a magnetic stand. The supernatants 
were used for western blot analysis.
Western blot analysis
Western blot analysis was performed as previously 
described [23]. Briefly, the membranes were incubated 
with anti-TLS (BD bioscience, 611385) or anti-GST 
antibody (Santa Cruz sc-459) for 1  h at room tempera-
ture. Then the membranes were washed with PBST for 
5 min, four times, and incubated with anti-mouse HRP-
conjugated IgG (Dako, P0161) or anti-rabbit HRP-con-
jugated HRP (Cell signaling, 70745). All the antibodies 
were diluted by 1 % skim milk to 1:2000. The signals were 
detected with SuperSignal West Pico substrate (Thermo 
Scientific).
RNA
The fragment 1–1 [r(GUUAAGAGGGUACGGU
GGUUUGAUGACACUG)], the 5′ end of the frag-
ment 1–1 [r(GUUAAGAGGGUAC)], the 3′ end of the 
fragment 1–1 [r(CGGUGGUUUGAUGACACUG)], 
G46A mutant of the 3′ end of the fragment 1–1 
[r(CGAUGGUUUGAUGACACUG)], G49A mutant 
of the 3′ end of the fragment 1–1 [r(CGGUGAUUUG 
AUGACACUG)] and U13 [r(UUUUUUUUUUUUU)] 
were synthesized, purified by HPLC and desalted by 
FASMAC Co., Ltd and Japan Bio Services Co., Ltd.
Expression and purification of 15N‑labelled TLS‑5
The plasmid containing TLS-5 fused to GST was a gener-
ous gift from Dr. Takanori Oyoshi (Shizuoka University). 
The expression and purification of GST–TLS-5 basically 
followed the reported protocol [24] except for using min-
imal medium (M9) containing 1  g/1L 15N-ammonium 
chloride to obtain 15N-labeled protein [25]. To improve 
the purity, cation exchange chromatography was also 
used in purification. The purified protein was dialyzed 
against titration buffer, 10 mM sodium phosphate buffer 
(pH 6.5) containing 100  mM NaCl, 1  mM MgCl2 and 
0.01  mM 2,2-dimethylsilapentane-5-sulfonic acid (DSS), 
and concentrated with Amicon Ultra (MWCO 3500, 
Millipore).
NMR spectroscopy
For the analysis of the secondary structure, the frag-
ment 1–1, the 5′ end of the fragment 1–1, the 3′ end 
of the fragment 1–1, G46A mutant of the 3′ end of the 
fragment 1–1, and G49A mutant of the 3′ end of the 
fragment 1–1 were dissolved, respectively, in ca. 10 mM 
potassium phosphate buffer (pH 6.2) containing 10 mM 
KCl and 0.01  mM DSS. For the titration experiments, 
the fragment 1–1, the 5′ end of the fragment 1–1, the 3′ 
end of the fragment 1–1 and U13 were dissolved, respec-
tively, in the titration buffer described above. Each RNA 
was added step by step to a 15N-labeled TLS-5 solution 
with molar ratios of 1:0, 1:0.5, 1:1.0, 1:1.5 and 1:2.0. NMR 
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spectra were recorded with a Bruker AVANCE III HD 
600 spectrometers equipped with a cryogenic probe with 
a Z-gradient at 5 °C. Chemical shift was calibrated with a 
DSS resonance. NMR data were processed and analyzed 
using TopSpin/XWIN-NMR (Bruker), NMRPipe [26] and 
Sparky (http://www.cgl.ucsf.edu/home/sparky/).
Abbreviation
ALS: amyotrophic lateral sclerosis; CCND1: cyclin D1; EMSA: electrophoretic 
mobility shift assay; FISH: fluorescence in situ hybridization; FUS: FUsed in 
Sarcoma; HRP: horseradish peroxidase; lncRNA: long noncoding RNA; NMR: 
nuclear magnetic resonance; PBS: phosphate buffered saline; pncRNA: pro-
moter-associated ncRNA; RRM: RNA recognition motif; SDS: sodium dodecyl 
sulfate; TLS: Translocated in LipoSarcoma; WCE: whole cell extract.
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